Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Email: nm@mva.org
    Phone: (M) +45 6141 8634 Linkedin

    Clinical Phase Immuno-Oncology Projects

    How far are current development projects and what is the expected road to marketing?

    Date: 22 November 2018
    Time: 14:30 – 18:00
    Venue: Søhuset, Venlighedsvej 10, 2970 Hørsholm
    Hosted by: Y-mAbs and Danish Biotek

    READ MORE & SIGN UP

    Programme:

    14.30

    Registration and networking

    15:00

    Welcome

    Hans Shambye Chairman, DANSK BIOTEK

    Claus Møller, CEO, Y-mAbs

    15.10

    Antibodies for treatment of high risk neuroblastoma and leptomeningeal metastases from neuroblastoma

    Claus Møller, CEO, Y-mAbs

    15.55

    ALECSAT for treatment of Glioblastoma and Soft Tissue Sarcoma

    Kim Arvid Nielsen, CEO, Cytovac

    16.40

    T-win technology for treatment across oncology indications

    Mai-Britt Zocca, CEO, IO Biotech

    17.25

    Networking

    Y-mAbs and DANSK BIOTEK will be serving snacks and refreshments

    The event is free of charge for members, however, non-members will be charged a fee of 500 DKK.

    Max. number of participants: 60 (first come first served basis).